KIPO publishes evergreen patent report

Published: 2009-10-13 06:59:00

Updated: 2009-10-13 06:59:00

The Korean Intellectual Property Office said that it has recently published a report titled “Evergreen patent strategies and patent dispute cases” to help local pharmaceutical companies develop more competitive drugs against the originator manufacturers.

Evergreen refers to a variety of legal ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK